Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H25N.ClH |
Molecular Weight | 279.848 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.C1CCN(CC1)C2(CCCCC2)C3=CC=CC=C3
InChI
InChIKey=BUAJNGPDPGKBGV-UHFFFAOYSA-N
InChI=1S/C17H25N.ClH/c1-4-10-16(11-5-1)17(12-6-2-7-13-17)18-14-8-3-9-15-18;/h1,4-5,10-11H,2-3,6-9,12-15H2;1H
Molecular Formula | C17H25N |
Molecular Weight | 243.3871 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Phencyclidine is an illegal, hallucinogenic drug that was initially used as an anesthetic agent in the 1950s and early 1960s, but was then withdrawn in 1965 because of dissociative hallucinogenic effects that were often disturbing and sometimes severe and prolonged. Phencyclidine is a noncompetitive NMDA (N-methyl-D-aspartate) receptor antagonist and glutamate receptor antagonist, but also interacts with other receptor sites, and may have effects with dopamine, opioid and nicotinic receptors. Phencyclidine disrupts the functioning of receptors for the neurotransmitter glutamate, which plays a major role in the perception of pain as well as in learning, memory, and emotion. It also influences the actions of the neurotransmitter dopamine, which causes the euphoria associated with drug use. Phencyclidine overdose deaths may occur after taking a large dose, though many phencyclidine related deaths result from delusions and other psychological consequences of the drug’s use. There have been reports of death due to accidental drowning, leaping from high places, and motor vehicle accidents in addition to violent episodes of self-mutilation, suicides, and homicides.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia. | 2001 |
|
Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. | 2001 |
|
Amaurosis fugax associated with phencyclidine inhalation. | 2001 |
|
Differential regulation of chromogranin A, chromogranin B and secretogranin II in rat brain by phencyclidine treatment. | 2001 |
|
Subchronic treatment with methamphetamine and phencyclidine differentially alters the adenosine A1 and A2A receptors in the prefrontal cortex, hippocampus, and striatum of the rat. | 2001 Apr |
|
Qualitative screening for drugs of abuse in hair using GC-MS. | 2001 Apr |
|
M100907, a selective 5-HT(2A) receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain. | 2001 Apr 13 |
|
Elucidating the role of muscarinic receptors in psychosis. | 2001 Apr 27 |
|
SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety. | 2001 Aug |
|
Natural segmentation of the locomotor behavior of drug-induced rats in a photobeam cage. | 2001 Aug 30 |
|
Combined alpha 2-adrenergic/D2 dopamine receptor blockade fails to reproduce the ability of clozapine to reverse phencyclidine-induced deficits in prepulse inhibition of startle. | 2001 Dec |
|
Behavioral and neurochemical effects of 3-OH-pip-BTCP, an active metabolite of BTCP in rats. | 2001 Dec 21 |
|
The adenosine A2A agonist CGS 21680 reverses the reduction in prepulse inhibition of the acoustic startle response induced by phencyclidine, but not by apomorphine and amphetamine. | 2001 Jul |
|
The nitric oxide synthase inhibitor, L-NAME, block phencyclidine-induced disruption of prepulse inhibition in mice. | 2001 Jul |
|
Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaque. | 2001 Jul |
|
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. | 2001 Jul |
|
Blockade of the central generator of locomotor rhythm by noncompetitive NMDA receptor antagonists in Drosophila larvae. | 2001 Jul |
|
[Acting out and psychoactive substances: alcohol, drugs, illicit substances]. | 2001 Jul-Aug |
|
Discrimination of pentobarbital doses and drug mixtures under fixed-ratio and fixed-interval reinforcement schedules. | 2001 Jun |
|
Psychotogenic properties of benzodiazepine receptor inverse agonists. | 2001 Jun |
|
Advances in schizophrenia. | 2001 Jun |
|
Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia? | 2001 Jun |
|
Interactions between 3-(Trifluoromethyl)-3-(m-[(125)I]iodophenyl)diazirine and tetracaine, phencyclidine, or histrionicotoxin in the Torpedo series nicotinic acetylcholine receptor ion channel. | 2001 Jun |
|
Schedule control of quantal and graded dose-effect curves in a drug-drug-saline discrimination. | 2001 Mar |
|
Lack of phencyclidine-induced effects in mice with reduced neuronal nitric oxide synthase. | 2001 May |
|
Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients. | 2001 May |
|
[The delta-sleep inducing peptide and its effect on the electroencephalogram and power spectrum density in rats with metaphit-induced epilepsy]. | 2001 May-Jun |
|
Role of nitric oxide in experimental models of psychosis in rats. | 2001 Nov |
|
Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma. | 2001 Nov |
|
Gamma vinyl-GABA differentially modulates NMDA antagonist-induced increases in mesocortical versus mesolimbic DA transmission. | 2001 Nov |
|
Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex. | 2001 Nov 15 |
|
Low concentration of DL-2-amino-5-phosphonovalerate induces epileptiform activity in guinea pig hippocampal slices. | 2001 Oct |
|
Effects of amphetamine, dexfenfluramine, diazepam, and other pharmacological and dietary manipulations on food "seeking" and "taking" behavior in non-human primates. | 2001 Oct |
|
Drug contamination of US paper currency. | 2001 Oct 1 |
|
NMDA receptors as targets for drug action in neuropathic pain. | 2001 Oct 19 |
|
Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620. | 2001 Oct 5 |
|
Phencyclidine-induced dysregulation of dopamine response to amphetamine in prefrontal cortex and striatum. | 2001 Sep |
|
Differential effects of delta 9-THC on spatial reference and working memory in mice. | 2001 Sep |
|
Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. | 2001 Sep |
|
Mechanism-based inactivators as probes of cytochrome P450 structure and function. | 2001 Sep |
|
Experience with urine drug testing by the Correctional Service of Canada. | 2001 Sep 15 |
|
Cembranoid and long-chain alkanol sites on the nicotinic acetylcholine receptor and their allosteric interaction. | 2001 Sep 18 |
|
MS-377, a novel selective sigma(1) receptor ligand, reverses phencyclidine-induced release of dopamine and serotonin in rat brain. | 2001 Sep 21 |
|
Analysis of overall gene expression induced by amphetamine and phencyclidine: novel targets for the treatment of drug psychosis and schizophrenia. | 2002 |
|
Substance abuse monitoring by the Correctional Service of Canada. | 2002 Feb |
|
Effect of MS-153 on the development of behavioral sensitization to stereotypy-inducing effect of phencyclidine. | 2002 Feb 1 |
|
Drug discrimination under concurrent variable-ratio variable-ratio schedules. | 2002 Jan |
|
NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys. | 2002 Jan |
|
Effect of MS-153 on the development of behavioral sensitization to locomotion- and ataxia-inducing effects of phencyclidine. | 2002 Mar |
|
Amphetamine inhibits the N-methyl-D-aspartate receptor-mediated responses by directly interacting with the receptor/channel complex. | 2002 Mar |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:08:57 GMT 2023
by
admin
on
Fri Dec 15 15:08:57 GMT 2023
|
Record UNII |
V1JZQ7GDTX
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
7471
Created by
admin on Fri Dec 15 15:08:57 GMT 2023 , Edited by admin on Fri Dec 15 15:08:57 GMT 2023
|
||
|
NCI_THESAURUS |
C245
Created by
admin on Fri Dec 15 15:08:57 GMT 2023 , Edited by admin on Fri Dec 15 15:08:57 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000088323
Created by
admin on Fri Dec 15 15:08:57 GMT 2023 , Edited by admin on Fri Dec 15 15:08:57 GMT 2023
|
PRIMARY | |||
|
C75101
Created by
admin on Fri Dec 15 15:08:57 GMT 2023 , Edited by admin on Fri Dec 15 15:08:57 GMT 2023
|
PRIMARY | |||
|
CHEMBL275528
Created by
admin on Fri Dec 15 15:08:57 GMT 2023 , Edited by admin on Fri Dec 15 15:08:57 GMT 2023
|
PRIMARY | |||
|
SUB22879
Created by
admin on Fri Dec 15 15:08:57 GMT 2023 , Edited by admin on Fri Dec 15 15:08:57 GMT 2023
|
PRIMARY | |||
|
13727
Created by
admin on Fri Dec 15 15:08:57 GMT 2023 , Edited by admin on Fri Dec 15 15:08:57 GMT 2023
|
PRIMARY | |||
|
V1JZQ7GDTX
Created by
admin on Fri Dec 15 15:08:57 GMT 2023 , Edited by admin on Fri Dec 15 15:08:57 GMT 2023
|
PRIMARY | |||
|
DBSALT000824
Created by
admin on Fri Dec 15 15:08:57 GMT 2023 , Edited by admin on Fri Dec 15 15:08:57 GMT 2023
|
PRIMARY | |||
|
956-90-1
Created by
admin on Fri Dec 15 15:08:57 GMT 2023 , Edited by admin on Fri Dec 15 15:08:57 GMT 2023
|
PRIMARY | |||
|
SUB09755MIG
Created by
admin on Fri Dec 15 15:08:57 GMT 2023 , Edited by admin on Fri Dec 15 15:08:57 GMT 2023
|
PRIMARY | |||
|
m8603
Created by
admin on Fri Dec 15 15:08:57 GMT 2023 , Edited by admin on Fri Dec 15 15:08:57 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID70893724
Created by
admin on Fri Dec 15 15:08:57 GMT 2023 , Edited by admin on Fri Dec 15 15:08:57 GMT 2023
|
PRIMARY | |||
|
1516003
Created by
admin on Fri Dec 15 15:08:57 GMT 2023 , Edited by admin on Fri Dec 15 15:08:57 GMT 2023
|
PRIMARY | |||
|
40902
Created by
admin on Fri Dec 15 15:08:57 GMT 2023 , Edited by admin on Fri Dec 15 15:08:57 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|